IRSA Inversiones y Representaciones IRS
$10.67 −$0.27 (-2.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.67 0.00%
Open$10.74
Prev close$10.94
Day range$10.52 – $11.12
Volume268.1K
Market cap$902.68M
P/E (TTM)7.6
Dividend yield12.58%
Fundamentals
Latest reported quarter: Q1, ended Sep 2026 · reported in ARS
RevenueARS 179.89B+4.4% YoY
Operating profitARS 78.58B-2.2% YoY
Net profit-ARS 6.38B-102.9% YoY
Diluted EPS-ARS 126.20-105.0% YoY
Free cash flowARS 42.44B-60.5% YoY
Operating cash flowARS 45.52B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin60.9%
Operating margin39.8%
Net margin26.7%
Return on equity8.4%
Return on assets4.0%
Return on invested capital7.9%
Current ratio1.90
Liabilities / assets49.1%
Cash & investmentsARS 529.19B
Total debtARS 1.00T
Net cash (debt)-ARS 475.33B
Free cash flow / sales11.5%
Where the revenue comes from
Quarter 2026/FY
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2027 Q1 (ARS) |
2026 ANNUAL (ARS) |
2026 Q4 (ARS) |
2026 Q3 (ARS) |
2026 Q2 (ARS) |
|---|---|---|---|---|---|
| Total Revenue as Reported | ARS 179.89B | ARS 657.60B | ARS 193.23B | ARS 144.71B | ARS 152.67B |
| Total Operating Revenue | ARS 179.89B | ARS 657.60B | ARS 193.23B | ARS 144.71B | ARS 152.67B |
| Cost of Revenue | ARS 68.71B | ARS 258.19B | ARS 84.14B | ARS 53.21B | ARS 56.59B |
| Gross Profit | ARS 111.19B | ARS 399.41B | ARS 109.10B | ARS 91.50B | ARS 96.07B |
| Operating Expense | ARS 32.60B | ARS 133.13B | ARS 45.23B | ARS 31.54B | ARS 19.14B |
| Selling and Admin Expenses | ARS 23.68B | ARS 96.37B | ARS 31.55B | ARS 31.20B | ARS 29.06B |
| -Selling & Marketing Expense | ARS 1.65B | ARS 12.18B | ARS 6.01B | ARS 8.08B | ARS 7.09B |
| -General & Admin Expense | ARS 22.04B | ARS 84.19B | ARS 25.54B | ARS 23.12B | ARS 21.97B |
| Depreciation & Amortization & Depletion | ARS 1.41B | ARS 4.76B | ARS 1.61B | – | – |
| -Depreciation & Amortization | ARS 1.41B | ARS 4.76B | ARS 1.61B | – | – |
| Other Taxes | ARS 6.03B | ARS 20.37B | ARS 5.90B | – | – |
| Other Operating Expenses | ARS 1.48B | ARS 7.98B | ARS 4.58B | ARS 340.00M | -ARS 9.93B |
| Operating Profit | ARS 78.58B | ARS 266.28B | ARS 63.86B | ARS 59.96B | ARS 76.94B |
| Net Non-Operating Interest Income (Expense) | -ARS 21.51B | -ARS 81.43B | -ARS 24.12B | ARS 62.44B | ARS 30.53B |
| Non-Operating Interest Income | ARS 1.76B | ARS 13.10B | ARS 2.58B | ARS 2.92B | ARS 1.74B |
| Non-Operating Interest Expense | ARS 20.40B | ARS 78.68B | ARS 24.07B | ARS 22.24B | ARS 20.93B |
| Total Other Finance Costs | ARS 2.87B | ARS 15.85B | ARS 2.63B | -ARS 81.76B | -ARS 49.71B |
| Other Income (Expense) | -ARS 60.81B | ARS 386.16B | ARS 194.51B | -ARS 166.08B | -ARS 25.61B |
| Gain on Sale of Security | -ARS 66.02B | ARS 343.84B | ARS 191.23B | -ARS 173.02B | -ARS 51.50B |
| Earnings from Equity Interest | ARS 4.45B | ARS 39.13B | ARS 19.17B | ARS 7.61B | ARS 15.53B |
| Special Income (Charges) | -ARS 3.98B | -ARS 17.72B | -ARS 21.31B | – | ARS 10.37B |
| -Less:Other Special Charges | ARS 307.00M | ARS 5.78B | ARS 1.08B | – | -ARS 10.37B |
| -Less:Write Off | ARS 3.67B | ARS 3.66B | – | – | – |
| -Gain on Sale of Property/Plant/Equipment | ARS 0.00 | ARS 2.00M | ARS 0.00 | – | – |
| Other Non-Operating Income (Expenses) | ARS 4.74B | ARS 20.90B | ARS 5.41B | -ARS 665.00M | – |
| Pretax Profit | -ARS 3.74B | ARS 571.01B | ARS 234.25B | -ARS 43.67B | ARS 81.86B |
| Tax | ARS 2.64B | ARS 150.03B | ARS 53.02B | -ARS 11.10B | ARS 9.32B |
| Net Profit | -ARS 6.38B | ARS 420.98B | ARS 181.24B | -ARS 32.57B | ARS 72.54B |
| Profit from Continuing Operations | -ARS 6.38B | ARS 420.98B | ARS 181.24B | -ARS 32.57B | ARS 72.54B |
| Minority Interests | ARS 4.19B | ARS 27.47B | ARS 15.26B | -ARS 2.38B | ARS 2.99B |
| Net Income to Parent Company | -ARS 10.57B | ARS 393.51B | ARS 165.97B | -ARS 30.18B | ARS 69.55B |
| Net Income to Common Stockholders | -ARS 10.57B | ARS 393.51B | ARS 165.97B | -ARS 30.18B | ARS 69.55B |
| Basic EPS | -ARS 126.20 | ARS 5,051.50 | ARS 2,081.00 | -ARS 394.00 | ARS 916.40 |
| Diluted EPS | -ARS 126.20 | ARS 5,051.50 | ARS 2,081.00 | -ARS 394.00 | ARS 838.00 |
| Dividend Per Share | ARS 0.00 | ARS 2,046.87 | ARS 0.00 | ARS 0.00 | ARS 2,046.87 |
| Asset Impairment Loss | – | ARS 3.66B | ARS 1.59B | – | – |
| -Less:Impairment of Capital Assets | – | ARS 11.94B | ARS 20.22B | – | – |
| -Gain on Sale Of Business | – | ARS 0.00 | ARS 0.00 | – | – |
Balance sheet
| Line item | 2027 Q1 (ARS) |
2026 ANNUAL (ARS) |
2026 Q4 (ARS) |
2026 Q3 (ARS) |
2026 Q2 (ARS) |
|---|---|---|---|---|---|
| Total Assets | ARS 5.01T | ARS 4.85T | ARS 4.85T | ARS 4.31T | ARS 4.18T |
| Total Current Assets | ARS 761.11B | ARS 797.72B | ARS 797.72B | ARS 715.87B | ARS 715.98B |
| Cash and Cash Equivalents & Short-Term Investments | ARS 529.19B | ARS 572.39B | ARS 572.39B | ARS 500.69B | ARS 519.45B |
| -Cash and Cash Equivalents | ARS 127.38B | ARS 112.99B | ARS 112.99B | ARS 54.47B | ARS 296.14B |
| -Short Term Investments | ARS 401.81B | ARS 459.40B | ARS 459.40B | ARS 446.22B | ARS 223.31B |
| Receivables | ARS 212.51B | ARS 205.47B | ARS 205.47B | ARS 164.39B | ARS 146.45B |
| -Accounts Receivable | ARS 211.85B | ARS 204.85B | ARS 204.85B | ARS 163.98B | ARS 146.09B |
| -Taxes Receivable | ARS 657.00M | ARS 621.00M | ARS 621.00M | ARS 408.00M | ARS 353.00M |
| Inventory | ARS 19.42B | ARS 19.85B | ARS 19.85B | ARS 50.79B | ARS 49.84B |
| Total Non-Current Assets | ARS 4.25T | ARS 4.06T | ARS 4.06T | ARS 3.59T | ARS 3.46T |
| Net PPE | ARS 97.09B | ARS 92.23B | ARS 92.23B | ARS 88.30B | ARS 76.44B |
| -Gross PPE | ARS 303.58B | ARS 285.05B | ARS 285.05B | ARS 266.43B | ARS 237.24B |
| -Accumulated Depreciation | -ARS 206.49B | -ARS 192.82B | -ARS 192.82B | -ARS 178.13B | -ARS 160.81B |
| Investments and Advances | ARS 311.43B | ARS 292.37B | ARS 292.37B | ARS 266.82B | ARS 245.41B |
| -Long Term Equity Investment | ARS 281.82B | ARS 263.39B | ARS 263.39B | ARS 237.53B | ARS 210.68B |
| Non Current Accounts Receivables | ARS 8.74B | ARS 8.69B | ARS 8.69B | ARS 6.75B | ARS 45.62B |
| Goodwill and Other Intangible Assets | ARS 29.52B | ARS 28.20B | ARS 28.20B | ARS 22.42B | ARS 20.81B |
| -Goodwill | ARS 7.88B | ARS 7.50B | ARS 7.50B | ARS 3.11B | ARS 2.84B |
| -Other Intangible Assets | ARS 21.64B | ARS 20.70B | ARS 20.70B | ARS 19.31B | ARS 17.97B |
| Non-Current Deferred Assets | ARS 12.07B | ARS 11.09B | ARS 11.09B | ARS 8.17B | ARS 7.60B |
| Total Liabilities | ARS 2.46T | ARS 2.43T | ARS 2.43T | ARS 2.27T | ARS 2.22T |
| Total Current Liabilities | ARS 400.44B | ARS 455.47B | ARS 455.47B | ARS 445.81B | ARS 330.61B |
| Payables | ARS 231.25B | ARS 243.65B | ARS 243.65B | ARS 233.48B | ARS 189.80B |
| -Accounts Payable | ARS 181.92B | ARS 177.84B | ARS 177.84B | ARS 143.82B | ARS 140.55B |
| -Total Tax Payable | ARS 49.34B | ARS 65.81B | ARS 65.81B | ARS 89.67B | ARS 49.24B |
| Current Accrued Expenses | ARS 12.69B | ARS 24.77B | ARS 24.77B | ARS 19.59B | ARS 15.68B |
| Short-Term Debt and Capital Lease Obligation | ARS 150.78B | ARS 181.08B | ARS 181.08B | ARS 103.98B | ARS 118.79B |
| -Current Debt | ARS 145.43B | ARS 175.71B | ARS 175.71B | ARS 98.63B | ARS 113.18B |
| -Current Capital Lease Obligation | ARS 5.35B | ARS 5.37B | ARS 5.37B | ARS 5.35B | ARS 5.61B |
| Current Provisions | ARS 5.61B | ARS 5.98B | ARS 5.98B | ARS 5.79B | ARS 6.35B |
| Other Current Liabilities | ARS 102.00M | – | – | ARS 82.96B | – |
| Total Non-Current Liabilities | ARS 2.06T | ARS 1.98T | ARS 1.98T | ARS 1.82T | ARS 1.89T |
| Long Term Accounts Payable and Other Payables | ARS 104.26B | ARS 78.11B | ARS 78.11B | ARS 68.74B | ARS 71.11B |
| Non-Current Accrued Expenses | ARS 133.00M | ARS 131.00M | ARS 131.00M | ARS 129.00M | ARS 128.00M |
| Long Term Debt and Capital Lease Obligation | ARS 859.10B | ARS 839.06B | ARS 839.06B | ARS 806.06B | ARS 875.82B |
| -Long Term Debt | ARS 851.17B | ARS 830.99B | ARS 830.99B | ARS 798.23B | ARS 872.13B |
| -Long Term Capital Lease Obligation | ARS 7.92B | ARS 8.08B | ARS 8.08B | ARS 7.83B | ARS 3.69B |
| Non-Current Liabilities | ARS 48.09B | ARS 47.83B | ARS 47.83B | ARS 41.43B | ARS 47.23B |
| Non-Current Deferred Liabilities | ARS 1.05T | ARS 1.01T | ARS 1.01T | ARS 907.85B | ARS 890.87B |
| Total Equity | ARS 2.55T | ARS 2.42T | ARS 2.42T | ARS 2.04T | ARS 1.96T |
| Stockholders' Equity | ARS 2.40T | ARS 2.28T | ARS 2.28T | ARS 1.92T | ARS 1.85T |
| Capital Stock | ARS 8.37B | ARS 8.37B | ARS 8.37B | ARS 8.02B | ARS 7.65B |
| -Common Stock | ARS 8.37B | ARS 8.37B | ARS 8.37B | ARS 8.02B | ARS 7.65B |
| Additional Paid-In Capital | ARS 902.33B | ARS 852.75B | ARS 852.75B | ARS 728.74B | ARS 712.65B |
| Retained Earnings | ARS 466.56B | ARS 450.91B | ARS 450.91B | ARS 281.29B | ARS 284.60B |
| Gains/Losses Not Affecting Retained Earnings | ARS 375.77B | ARS 353.70B | ARS 353.70B | ARS 337.91B | ARS 300.69B |
| Other Equity Interests | ARS 650.24B | ARS 614.04B | ARS 614.04B | ARS 574.62B | ARS 549.11B |
| Minority Interests | ARS 145.51B | ARS 140.66B | ARS 140.66B | ARS 115.88B | ARS 108.67B |
| Other Non-Current Assets | – | ARS 1.00M | ARS 1.00M | – | – |
| Less: Treasury Stock | – | – | – | -ARS 8.21B | – |
Cash flow
| Line item | 2027 Q1 (ARS) |
2026 ANNUAL (ARS) |
2026 Q4 (ARS) |
2026 Q3 (ARS) |
2026 Q2 (ARS) |
|---|---|---|---|---|---|
| Operating Cash Flow | ARS 45.52B | ARS 151.29B | ARS 32.52B | ARS 34.53B | -ARS 25.45B |
| Net cash flow from continuing operations | ARS 45.52B | ARS 151.29B | ARS 32.52B | ARS 34.53B | -ARS 25.45B |
| Net Income from Continuing Operations | -ARS 6.38B | ARS 420.98B | ARS 181.24B | -ARS 9.08B | ARS 30.87B |
| Gain/Loss from Continuing Operations | ARS 61.79B | -ARS 246.64B | -ARS 189.33B | ARS 141.78B | ARS 90.81B |
| Depreciation & Depletion & Amortization | ARS 8.12B | ARS 16.04B | ARS 5.13B | ARS 4.39B | ARS 2.78B |
| Deferred Tax | ARS 2.64B | ARS 150.03B | ARS 53.02B | -ARS 1.78B | -ARS 11.83B |
| Other Non-Cash Items | ARS 2.87B | -ARS 131.32B | -ARS 22.25B | -ARS 89.43B | -ARS 74.66B |
| Change in Working Capital | -ARS 10.32B | ARS 15.52B | ARS 6.72B | ARS 3.93B | ARS 2.03B |
| -Change in Receivables | ARS 17.23B | ARS 20.51B | -ARS 118.00M | ARS 29.57B | ARS 5.20B |
| -Change in Inventory | ARS 2.38B | ARS 1.87B | ARS 390.00M | -ARS 848.00M | -ARS 609.00M |
| -Change in Other Current Liabilities | -ARS 16.12B | – | – | – | – |
| -Change In Other Working Capital | -ARS 13.81B | -ARS 861.00M | -ARS 207.00M | ARS 1.93B | -ARS 920.00M |
| Net cash flow from investing | ARS 20.28B | -ARS 283.59B | -ARS 12.92B | -ARS 237.03B | ARS 120.18B |
| Net Cash Flow from Continuing Investing Activities | ARS 20.28B | -ARS 283.59B | -ARS 12.92B | -ARS 237.03B | ARS 120.18B |
| Net PPE Purchase and Sale | -ARS 2.65B | -ARS 8.44B | -ARS 1.15B | -ARS 3.18B | -ARS 2.06B |
| Net Intangibles Purchase and Sale | -ARS 427.00M | -ARS 1.06B | -ARS 483.00M | -ARS 287.00M | -ARS 103.00M |
| Net Business Purchase and Sale | ARS 0.00 | -ARS 11.93B | -ARS 4.32B | -ARS 656.00M | ARS 1.48B |
| Net Investment Purchase and Sale | ARS 44.60B | -ARS 231.81B | ARS 2.16B | -ARS 162.68B | ARS 72.87B |
| Net Other Investing Changes | ARS 1.06B | ARS 1.61B | ARS 1.09B | ARS 485.00M | -ARS 189.00M |
| Financing Cash Flow | -ARS 57.09B | ARS 12.57B | ARS 24.75B | -ARS 56.18B | ARS 125.56B |
| Net Cash Flow from Continuing Financing Activities | -ARS 57.09B | ARS 12.57B | ARS 24.75B | -ARS 56.18B | ARS 125.56B |
| Net Issuance Payments Of Debt | -ARS 21.39B | ARS 240.10B | ARS 42.38B | -ARS 9.86B | ARS 263.95B |
| Cash Dividends Paid | -ARS 1.69B | -ARS 165.84B | -ARS 10.51B | -ARS 13.58B | -ARS 141.75B |
| Proceeds from Stock Option Exercised | ARS 0.00 | ARS 7.40B | ARS 1.09B | ARS 1.35B | -ARS 647.00M |
| Net Other Financing Charges | ARS 227.00M | ARS 1.74B | ARS 1.31B | ARS 257.00M | ARS 105.00M |
| Ending Cash Balance | ARS 127.38B | ARS 112.99B | ARS 112.99B | ARS 54.47B | ARS 296.14B |
| Net Change in Cash | ARS 8.71B | -ARS 119.74B | ARS 44.35B | -ARS 258.67B | ARS 220.30B |
| Beginning Cash Balance | ARS 119.56B | ARS 236.14B | ARS 54.47B | ARS 296.14B | ARS 123.14B |
| Effect of Exchange Rate Changes | -ARS 63.00M | ARS 284.00M | -ARS 140.00M | -ARS 691.00M | ARS 1.49B |
| Free Cash Flow | ARS 42.44B | ARS 141.79B | ARS 30.88B | ARS 31.07B | -ARS 27.58B |
| -Change in Payables and Accrued Expense | – | -ARS 6.00B | ARS 6.65B | -ARS 26.72B | ARS 2.28B |
| Net Common Stock Issuance | – | ARS 0.00 | ARS 0.00 | ARS 0.00 | ARS 0.00 |
No comments yet — be the first to weigh in on IRS.
Sign in to join the discussion.